SMTL ID : 1q43.3 (3 other biounits)

HCN2I 443-640 in the presence of cAMP, selenomethionine derivative

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

homo-octamer

Ligands

8 x CMP: ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE(Non-covalent)

CMP.1: 15 residues within 4Å: Chain A: I.107, V.126, M.134, L.136, F.142, G.143, E.144, I.145, C.146, R.153, T.154, A.155, V.157, R.194, R.197 9 PLIP interactions: 9 interactions with chain A Hydrogen bonds: A:G.143, A:E.144, A:E.144, A:I.145, A:C.146, A:T.154, A:R.194, A:R.194 Salt bridges: A:R.153 CMP.2: 15 residues within 4Å: Chain B: I.107, V.126, M.134, L.136, F.142, G.143, E.144, I.145, C.146, R.153, T.154, A.155, V.157, R.194, R.197 9 PLIP interactions: 9 interactions with chain B Hydrogen bonds: B:G.143, B:E.144, B:E.144, B:I.145, B:C.146, B:T.154, B:R.194, B:R.194 Salt bridges: B:R.153 CMP.3: 15 residues within 4Å: Chain C: I.107, V.126, M.134, L.136, F.142, G.143, E.144, I.145, C.146, R.153, T.154, A.155, V.157, R.194, R.197 9 PLIP interactions: 9 interactions with chain C Hydrogen bonds: C:G.143, C:E.144, C:E.144, C:I.145, C:C.146, C:T.154, C:R.194, C:R.194 Salt bridges: C:R.153 CMP.4: 15 residues within 4Å: Chain D: I.107, V.126, M.134, L.136, F.142, G.143, E.144, I.145, C.146, R.153, T.154, A.155, V.157, R.194, R.197 9 PLIP interactions: 9 interactions with chain D Hydrogen bonds: D:G.143, D:E.144, D:E.144, D:I.145, D:C.146, D:T.154, D:R.194, D:R.194 Salt bridges: D:R.153 CMP.5: 14 residues within 4Å: Chain E: I.107, V.126, M.134, L.136, F.142, G.143, E.144, I.145, C.146, R.153, T.154, A.155, V.157, R.194 9 PLIP interactions: 9 interactions with chain E Hydrogen bonds: E:G.143, E:E.144, E:E.144, E:I.145, E:C.146, E:T.154, E:R.194 Water bridges: E:R.194 Salt bridges: E:R.153 CMP.6: 14 residues within 4Å: Chain F: I.107, V.126, M.134, L.136, F.142, G.143, E.144, I.145, C.146, R.153, T.154, A.155, V.157, R.194 9 PLIP interactions: 9 interactions with chain F Hydrogen bonds: F:G.143, F:E.144, F:E.144, F:I.145, F:C.146, F:T.154, F:R.194 Water bridges: F:R.194 Salt bridges: F:R.153 CMP.7: 14 residues within 4Å: Chain G: I.107, V.126, M.134, L.136, F.142, G.143, E.144, I.145, C.146, R.153, T.154, A.155, V.157, R.194 9 PLIP interactions: 9 interactions with chain G Hydrogen bonds: G:G.143, G:E.144, G:E.144, G:I.145, G:C.146, G:T.154, G:R.194 Water bridges: G:R.194 Salt bridges: G:R.153 CMP.8: 14 residues within 4Å: Chain H: I.107, V.126, M.134, L.136, F.142, G.143, E.144, I.145, C.146, R.153, T.154, A.155, V.157, R.194 9 PLIP interactions: 9 interactions with chain H Hydrogen bonds: H:G.143, H:E.144, H:E.144, H:I.145, H:C.146, H:T.154, H:R.194 Water bridges: H:R.194 Salt bridges: H:R.153

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zagotta, W.N. et al., Structural basis for modulation and agonist specificity of HCN pacemaker channels. Nature (2003)

Release Date

2003-09-09

Peptides

Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2: ABCDEFGH

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

C
A

D
A

E
B

F
B

G
B

H
B

Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2

Related Entries With Identical Sequence